Approval · Notice of Compliance 5071 · 1995
WELLFERON: Notice of Compliance 5071
Issued March 27, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5071
- Date
- March 27, 1995
- Company
- Burroughs Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 5 mega units/ml
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| WELLFERON | 02161176 | — |
Medicinal ingredients
- INTERFERON ALPHA-N1 (INS) 5,000,000 UNIT per ML